Of note, Cardile et al. [69] found significant increases in pRKIP in non-metastatic melanoma (Clark I–II) with respect to control and metastatic melanomas thus combined analysis of RKIP and pRKIP might be a useful tool to obtain early diagnosis and prognosis. Here, PEBP1 is linked to metastatic melanoma.